Computed tomographic (CT) scanning has been used to assess the extent of local spread in 85 patients with rectal carcinoma. In 37 patients with carcinoma of the rectum who were scanned before surgery, good correlation was found between the extent of local invasion, as assessed by scanning, and that demonstrated at operation by histological assessment. Scanning is not a reliable method for assessing regional lymph node involvement. Forty-eight patients presented with recurrent rectal carcinoma after previous rectal excision (30 patients after abdominoperineal and 18 patients after anterior resection). CT scanning was shown to be a varuable tool in establishing the diagnosis of recurrent tumour. Most of these patients have spread which precludes further curative surgery. CT may identify those patients who have a resectable recurrence, but is especially valuable in planning radiotherapy which may be used for palliation. / /
Introduction
Computed tomographic (CT) scanning has been suggested as an aid to assess local spread in patients with carcinoma of the rectum (Dixon et al. 1981 , Meyer et al. 1983 , Van Waes et al. 1983 . Digital examination and proctoscopy are reasonably accurate guides to local spread when the assessment is made by an experienced clinician and when the. tumour is low in the rectum (Nicholls et al. 1982) . Clinical assessment is less reliable when the patient is obese, or the tumour is in the upper third of the rectum.
Clinical detection of recurrent rectal carcinoma is difficult, especially in those patients who have had an abdominoperineal (AP) resection. Ultrasound scanning and 'second-look' operations can be used to assess the site and extent of recurrent tumour. However, even in second-look operations, Gunderson & Sosin (1974) found that the exact superior extent of disease was difficult to assess.
Theoretically the anatomical structure of the pelvis, with fat surrounding the pelvic organs, makes it ideal for the use of CT to detect recurrent tumour and to assess its extent (Haaga 1978) . Various authors have reported on the value of CT in the detection of recurrent rectal carcinoma (Husband et al. 1980 , Leer et al. 1980 , Lee et al. 1981 , Zaunbauer et al. 1981 , Asbell 1981 .
We have carried out a prospective study into the value of CT scanning in patients with new and recurrent rectal carcinoma.
Material and methods
Thirty-seven patients with biopsy-proven rectal carcinoma had a CT scan within two weeks of definitive surgery; there were 21 males and 16 females, their ages ranging from 48 to 80 years (average 67.8). The CT scans were reviewed without knowledge of the surgical findings. The operative findings and histological assessment of the resected material were detailed by the surgeon (PFS) without knowledge of the CT scan findings. The CT scans of 48 patients referred from hospitals in the North West region of England to the Christie Hospital for palliative radiotherapy for recurrent rectal carcinoma were also reviewed. These patients were divided into two groups: Group 1 -30 patients with recurrent tumour after AP resection; Group 2 -18 patients with recurrent tumour after an anterior resection. All patients in Group I had increasingly severe pelvic pain, whilst those in Group 2 had progressive symptoms associated with rectal bleeding or discharge.
All patients were scanned using an EMI 7070 scanner with a 3-second scan time. Contiguous 1 cm thick sections were obtained from the pubic symphysis to the iliac crest. One section was obtained at renal hilar level to assess the collecting systems. The patient preparation before scanning included a low residue diet for 48 hours, 10 ml of Isogel (ispaghula husk) twice daily for 48 hours, 250 ml of a 5% volume by volume solution of Gastrografin (meglumine diatrizoate) 12 hours and 3 hours before the scan. Immediately before the scan patients were given 20 mg of Buscopan (hyoscine butylbromide) intravenously to paralyse the bowel and 50 ml of Isopaque Cerebral 280 (meglumine metrizoate and calcium metrizoate) intravenously to outline the ureters and bladder. A tampon was used as a vaginal marker in women. Air as a negative contrast agent was inserted via a rectal catheter in those patients with primary rectal carcinoma and those who had had an anterior resection. Patients were usually scanned supine unless they had severe pelvic pain when they were scanned prone.
Results

CTfindings in primary rectal carcinoma
The CT scans were reviewed to determine the site and extent of the primary tumour, evidence of extension into the perirectal space or presacral region, adjacent organ involvement and the presence of local or regional lymph node metastases.
CT detected the primary tumour in all patients. It appeared as thickening of the rectal wall varying between 10 and 31 mm, with an average of 19.4 + 6.6 mm ( Figure 1 ). The tumour length was correctly estimated in 34 patients. An overestimation of more than 2 cm was made in 3 patients. The circumferential extent of disease was correctly estimated in 19 patients, underestimated in 12, and overestimated in 6. The accuracy of CT in detecting disease outside the rectal wall is shown in Table 1 . There were 20 patients with evidence of tumour extension into the perirectal space at the time of surgery; CT correctly identified 19 of these and the tumour extension appeared as soft tissue densities extending from the rectum into the perirectal space ( Figure 1 ). Seven patients who on CT were thought to have tumour extension had no evidence of this at surgery.
The presacral fat plane was obliterated in 11 patients on CT; only 7 of these had tumour involvement at this site at surgery. Two patients had involvement of the presacral area not detected on CT. Of the 10 patients with extension of tumour to the pelvic side wall at surgery, CT detected 6 of these. There was no patients who had obliteration of the fat plane between the tumour and the pelvic wall on CT who did not have tumour at this site at the time of surgery. Muscle involvement occurred in 5 patients. CT demonstrated this in 3 patients. In 2 patients muscle was thought to be involved on the CT scan, but this was not apparent at surgery.
There was correlation between the CT findings and surgery when there was extension of tumour to involve the prostate (3 patients), seminal vesicles (2 patients), uterus (1 patient) and bone (4 patients). Two patients had a normal appearance of the sacrum on CT scan and were suspected of having bone involvement at surgery. Minor uterine involvement at surgery was unsuspected on CT in one patient.
CT demonstrated lymph nodes greater than 1 cm in diameter in the perirectal region in 8 patients. Metastases were found in 7 patients. Soft tissue densities less than 1 cm in diameter were seen in 14 patients on CT, but only 4 of these had metastases at surgery. In 2 patients lymph node metastases found at surgery were not demonstrated on the CT scan. Eight patients had lymph node metastases in the drainage area of the upper two-thirds of the rectum; CT identified only one of these. In 3 patients CT demonstrated nodes between 1 and 1.3 cm diameter in the drainage area but these were not metastatic.
CT failed to detect minor invasion of the bladder in 2 patients. In another patient, previously treated by radiotherapy for bladder carcinoma, the rectal tumour was inseparable from the bladder on the CT scan. Histology of the combined anterior resection and cystectomy specimen showed rectal tumour invading the bladder.
CTfindings in recurrent rectal carcinoma
The interval between initial surgery and the CT scan varied between two months and eight years (average 21.2 months). The sites of recurrent tumour are detailed in Table 2 .
After AP resection the commonest site of recurrence was in the presacrococcygeal area, occurring in 24 of 30 patients (80%) (Figure 2) . In 3 patients recurrent tumour was also seen anterior to the presacral mass, in 2 patients disease extended inferiorly onto the perineum, -0 (7) 87.5% Distant (regional) lymph nodes 1 8 0 7
(1) 12.5% Muscle 5 5 2 2
(3) 60% and in another 2 patients additional disease was seen on the pelvic side wall. In 4 patients (13%) the only evidence of recurrent tumour was on the pelvic side wall. Two of these patients had obvious lymphadenopathy whilst the other 2 had a mass lesion. In one patient recurrent disease was seen as a mass within the centre of the pelvis. After anterior resection, 8 of 18 patients (44%) had evidence of tumour recurrence in the rectum at the site of anastomosis. Five of these patients also had tumour in the perirectal tissues which was in continuity with the disease of the rectum (Figure 3 ). In 6 patients (33%) recurrent tumour was seen in the perirectal tissues in continuity with an apparently normal rectum. In 2 patients recurrent tumour occupied the centre of the pelvis. In one patient the only evidence of recurrence was on the pelvic side wall. Table 3 details the other sites of involvement within the pelvis either from direct extension of the recurrent tumour or from metastatic spread. Involvement of the pyriformis muscle was seen in 14 patients. The gluteus maximus was involved in 4 patients by extension of disease from the pyriformis muscle (Figure 4 ). The iliopsoas muscle was considered to be Figure 3 . Tumour recurrence after anterior resection. There is thickening of the anterior and lateral walls of the rectum (large arrow) with an abnormal mass in the perirectal space in continuity with the rectum (small arrow) iK~~; i l l Figure 4 . Tumour recurrence after AP resection with involvement of the pyriformis muscle (large arrow) on both sides and the left gluteus maximus (small arrow). Tumour also involves the sacrum involved by tumour in 2 patients, one of whom had adjacent lymphadenopathy. Bone involvement occurred in 1 I patients; this was always by direct posterior extension of tumour into the sacrum or coccyx (Figure 4 ). Direct involvement of the bladder was seen in 4 patients, prostate gland in 2 patients, the seminal vesicle in one patient and the vagina in one patient. Metastatic lymphadenopathy to regional or distant nodes occurred in 14 patients. Eight patients had evidence of pelvic lymphadenopathy, 3 patients abdominal lymphadenopathy and 3 patients inguinal lymphadenopathy. All patients had had an intravenous urogram (IVU) performed at the referring hospital before the CT examination in order to exclude renal tract obstruction. In 7 patients obstructive uropathy demonstrated on the IVU was confirmed by CT, which showed ureteric obstruction by recurrent pelvic tumour in 6 patients and by pelvic lymphadenopathy in the other patient. In 4 patients with a neuropathic bladder CT revealed a large distended bladder; 3 of these patients had extensive sacral bone destruction. In 2 female patients a separate lobular mixed density mass was seen within the pelvis. The CT appearances were those of an ovarian tumour.
Discussion
In patients with new carcinoma of the rectum we have demonstrated good correlation between the CT and surgical findings of local tumour spread, including the involvement of local lymph nodes. The detection of metastases to regional nodes by CT was poor. This is an important limitation of the technique and has been documented by Dixon et al. (1981) . Other studies have shown a correlation of CT with surgery and local tumour spread but make no mention of Iymph node involvement , Van Waes et al. 1983 , Meyer et al. 1983 . Whilst CT may have little advantage over digital examination by experienced clinicians in early-stage tumours arising low in the rectum (Nicholls et al. 1982) , the method is more useful in high rectal tumours. The main advantage of CT is that it provides a more accurate preoperative assessment of tumour spread in extensive disease. This is important in those patients with significant extrarectal spread who are to have preoperative radiotherapy, as the CT scan provides optimal radiotherapy planning. In recurrent carcinoma of the rectum, CT is invaluable in confirming the clinical impression of recurrence. It allows early diagnosis and an accurate assessment of the extent of disease for radiotherapy planning and for guided needle biopsy if indicated. Problems in radiological diagnosis may arise when there are postoperative inflammatory masses or postoperative fibrosis (Husband et al. 1980 , Lee et al. 1981 . In this series no inflammatory masses were seen and the changes that could be attributed to postoperative fibrosis were not those seen in tumour recurrence, supporting the findings of Lee et al. (1981) . Fluid-filled loops of small bowel did not cause diagnostic problems.
Few patients have an operable recurrence (Rosenberg 1979 ), but CT scanning will assist in demonstrating this small subgroup. If patients are being monitored after surgery by serial carcinoembryonic antigen (CEA) estimations, then CT may help in localizing the site of recurrence when the CEA level first rises. Early detection of recurrence by this combined approach may identify a further subgroup of patients with operable disease (Allen-Mersh 1984). Two patients in this series were found to have an ovarian lesion. Identification of an ovarian lesion is of practical importance as it would be an indication for further surgery if it is the only site of abnormality (Blamery et al. 1981 , Mackeigan & Ferguson 1979 .
In the majority of patients in this series tumour recurred locally: in the presacrococcygeal region in patients after an AP resection, and in the rectum or adjacent perirectal tissues in patients after an anterior resection. These findings correlate with the patterns of recurrence after operation described by Cass et al. (1976) and previous reports on the CT scan findings in recurrent rectal carcinoma (Husband et al. 1980 , Leer et al. 1980 , Zaunbauer et al. 1981 . The site of tumour recurrence in the pelvis is of particular importance with respect to the planning of adjuvant radiotherapy trials in carcinoma of the rectum. If high-dose radiotherapy is to be given immediately before or after radical surgery, the probability of damage to surrounding normal tissues is proportional to the volume of those tissues irradiated. There is no evidence from this series that the entire pelvis should be included in the radiotherapy fields. The volume at risk following AP resection or anterior resection appears to be in the immediate vicinity of the operation bed and is comparatively small.
